Learning Objectives:

1. Understand the efficacy of low-dose continuous olanzapine in improving appetite and weight gain in patients with locally advanced or metastatic cancer undergoing chemotherapy.

2. Identify dosage that has been associated with reduced stroke risk.

Session date: 
04/04/2024 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ame Proietti & Mercedes Telleria